创模生物科技(北京)有限公司

CN / En

NEWS

InnoModels Biotechnology: Luminex Platform Features in Detail

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-05-13 15:00
  • Views:

(Summary description)With the rapid development of life science technology, there is a growing demand for efficient, accurate and high-throughput biomolecular detection platforms for researchers. Against this backdrop, the Luminex platform of InnoModels Biotechnology has emerged and occupied a pivotal position in life science research with its unique advantages. In this article, we will analyze the features of the Luminex platform in detail, and reveal how it has revolutionized traditional biomolecular detection methods.

InnoModels Biotechnology: Luminex Platform Features in Detail

(Summary description)With the rapid development of life science technology, there is a growing demand for efficient, accurate and high-throughput biomolecular detection platforms for researchers. Against this backdrop, the Luminex platform of InnoModels Biotechnology has emerged and occupied a pivotal position in life science research with its unique advantages. In this article, we will analyze the features of the Luminex platform in detail, and reveal how it has revolutionized traditional biomolecular detection methods.

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-05-13 15:00
  • Views:
Information

With the rapid development of life science technology, there is a growing demand for efficient, accurate and high-throughput biomolecular detection platforms for researchers. Against this backdrop, the Luminex platform of InnoModels Biotechnology has emerged and occupied a pivotal position in life science research with its unique advantages. In this article, we will analyze the features of the Luminex platform in detail, and reveal how it has revolutionized traditional biomolecular detection methods.
The core technology of the Luminex platform lies in the application of fluorescence-encoded magnetic beads/microspheres. These microspheres are fluorescently encoded to carry multiple antibodies or gene probes specific for different biomolecules at the same time. This design allows the Luminex platform to accurately quantify up to 2-500 different biomolecules in a single tube, greatly improving detection efficiency.
The platform integrates a variety of advanced technologies such as flow principles, laser analysis, and high-speed digital signal processing to realize parallel analysis of multiple indicators. Laser irradiation of the fluorescence on the magnetic beads can quickly identify the captured antibody labeled by the beads, and then determine the detection items corresponding to the beads. This design not only improves the accuracy of the test, but also makes the operation process easier, greatly reducing the experimental cost and time cost.

 


The Luminex platform offers significant advantages in assay performance. Measurement results are similar to those of traditional methods such as ELISA in terms of accuracy, precision, and sensitivity. In addition, the Luminex platform has a wider linear range, which further enhances the reliability of the assay results.
It is worth mentioning that the Luminex platform excels in multiplexed detection. By freely combining different fluorescence-encoded magnetic beads, researchers can analyze multiple target molecules simultaneously in a single experiment. This multi-detection capability not only reduces the consumption of biological samples, but also allows for more accurate analysis of correlations between multiple target molecules.
In addition, the Luminex platform has excellent application scalability. In addition to immunoassay, nucleic acid research, enzyme analysis, etc., the platform can also be applied to pathogen detection and typing, HLA typing, miRNA expression profiling, transcription factor research, and many other applications. This makes the Luminex platform have a wide range of application prospects in basic life science research and medical diagnostic technology development.
In conclusion, with its unique fluorescence-encoded magnetic bead technology, its ability to analyze multiple indicators in parallel, and its wide range of applications, InnoModels' Luminex platform has demonstrated strong competitiveness in the field of biomolecular testing. With the continuous development and improvement of the technology, it is believed that the Luminex platform will bring more breakthroughs and innovations to life science research and medical diagnosis in the future.   

Keyword:

In the vast starry sky of biomedical research, InnoModels Biotechnology (Beijing) Co., Ltd. is like a bright star, illuminating the journey of oncology and tumor immunology drug development with its unique PDX in vivo efficacy model. Today, let's go into InnoModels Biotechnology to learn more about its industry-leading PDX in vivo efficacy model and explore its unlimited potential in drug discovery and development.
In the vast field of cancer research and drug development, InnoModels Biotechnology (Beijing) Co., Ltd. provides powerful support to scientists and doctors with its leading CDX (Cell line-derived xenograft tumor) model platform. The platform not only has diverse tumor cell lines, but also is equipped with a team of experienced experts and advanced experimental technologies, which are dedicated to promoting innovation in biomedical research and clinical treatment.
In the field of life sciences, in vitro killing experimental platform is gradually becoming an important tool for drug development and cell research. Among them, the in vitro killing experimental platform of InnoModels Biotechnology has attracted the attention of many researchers with its unique technical advantages and wide application prospects. In this paper, we will introduce in detail the features and advantages of InnoModels' in vitro killing platform and its applications in scientific research.
In the vast starry sky of biomedical research, InnoModels Biotechnology (Beijing) Co., Ltd. is leading the forefront of tumor and tumor immunotherapy research with its unique in vivo tumor experimental platform, which is like a bright star. The platform not only integrates the most advanced technologies and experimental methods, but also devotes itself to providing a new generation of experimental animal models close to the clinic
In the vast field of life science and drug discovery, in vitro experimental platforms play a crucial role. As a leader in this field, InnoModels Biotechnology (Beijing) Co., Ltd. provides scientists with a highly controlled and precise experimental environment with its in vitro killing platform, which greatly facilitates the screening of new drugs, the study of drug mechanisms, and the development of immunotherapies.
In the broad field of tumor research and new drug development for tumor immunotherapy, InnoModels Biotechnology (Beijing) Co., Ltd. has successfully launched a high mesenchymal tumor transplantation model by virtue of its profound accumulation and technological innovation in the field of model construction, which provides strong support for tumor research and drug development. In this article, we will introduce in detail how InnoModels Biotechnology has made a breakthrough in this field, and explain the importance of high mesenchymal tumor models and their application prospects.
Previous page
1
2
42

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL:15010000264        13810723384

Address:Building 14, Life Valley, Shuangying West Road, Changping District, Beijing

Chuangmo Biotechnology (Beijing) Co., Ltd. Beijing ICP 222*** 98-1 Website Construction: China Enterprise Power Beijing Second Branch Company

北京中因科技有限公司

创模生物科技(北京)有限公司